Integrum and Garwood Medical Devices Discuss Commercial Collaboration to Conduct Joint Research to Expand Treatment Indications for the OPRA™ Implant System.
Integrum AB (Nasdaq First North Growth Market: INTEG B), a worldwide leader in helping individuals with amputations improve their quality of life through Integrum’s OPRA™ Implant System , have signed a memorandum of understanding with Garwood Medical Devices, LLC , an emerging Buffalo-based company developing groundbreaking BioPrax™ technology, which eliminates antibiotic-resistant bacterial biofilm infections associated with implants. The intent is to explore a collaboration aimed at expanding treatment